DALLAS, Ga. — About a 40-minute drive from Atlanta’s Hartsfield Jackson International Airport, in a community that bears little resemblance to the Texas city that shares the same name, a new health care facility has risen, almost overnight, that seeks, with considerable success, to address the problems many Americans face in gaining access to affordable
This issue of Chain Drug Review includes — indeed highlights — our editors’ choices for the most outstanding retailers of the year that ended last month. We at CDR do not take these awards lightly. Nor do we give our selections a cursory review before moving on to other subjects and future issues of the
Has anyone in the chain drug retailing community visited the new Wegmans in Brooklyn? Has anyone been to Dallas, Ga., to experience the bold and exciting new Walmart experiment in affordable and accessible health care? Has chain drug retailing become so complacent and sure of itself that the newest and most stunning mass retailing innovations
The mass retailing community is abuzz over Walmart’s most recent initiative, the opening earlier this fall of an innovative health care facility in the small Georgia town of Dallas, northwest of Atlanta. Those industry people who have journeyed to Dallas to visit the new facility, which adjoins a Walmart Supercenter, and those who have merely
Some considerable time has passed since the retail and wholesale drug store business has found itself on the wrong side of the headlines, allegedly the perpetrator of offenses it usually defends against or, at the least, is ignorant of. Such, unfortunately, is not the case in the ill-omened opioid situation. In this instance, several of
Among the retail trade organizations, one association has emerged as the driving force of the industry it serves, the catalyst for inclusion, and the prime determinator of the directions mass retailing embarks on and the success the industry is achieving in taking stances and making lasting impressions. That organization is the National Association of Chain
The Emerson Group is celebrating an anniversary, the company’s 25th, I believe. The exact date is either later this year or early next year or sometime soon. No matter. The point here is that the Emerson Group is a vital enterprise that improves every organization it touches, while improving its efficiency and work ethic in
The news out of Rhode Island that Judy Sansone, chief merchant at CVS Pharmacy, will shortly retire signals more than the end of a remarkable and productive retail career. It marks the end of the way chain drug stores have done business since they eclipsed independent pharmacies as the outlet of choice among drug store
A recent event affirmed a retailing revolution. Representatives from some of America’s leading mass market retailers gathered in New York City to accept awards for the contributions they have made to their companies and the retailing community. What was remarkable — or perhaps not so — was that these award winners were all women. They
Chain drug retailing has thus far largely escaped the repercussions of the opioid epidemic, an ongoing tragedy which has seen so many people become addicted to pharmaceutical products that, when taken as prescribed and properly managed, can bring needed relief to patients with serious illnesses or injuries. Several of America’s most prominent pharmaceutical houses have
While retailing in the United States has hit a snag, one marked by a dearth of innovation and a scarcity of bold leadership, the state of the art elsewhere in the world is alive and well. While traditional retailers have for now run out of new ideas, the art itself is thriving. Examples abound. In
In an ever-changing retail universe, a world where today’s bright hope is tomorrow’s used-to-be, the National Association of Chain Drug Stores’ Annual Meeting, held each spring, remains the standard by which retail meetings are, or should be, judged. To borrow a well-known phrase, to those who regularly attend the NACDS Annual Meeting, no explanation is
The current year is two-thirds finished, and the good news is most notable by its absence. Sales are soft, earnings elusive. Hot new items are few and far between. Growth is nowhere to be seen. Meaningful executive job shifts have been all but absent. Mergers and acquisitions have failed to materialize — and even those
In the aftermath of the failed Walgreens Boots Alliance Inc. (WBA) acquisition of Rite Aid Corp., very little has happened. Rather, it’s like the event itself, or the nonevent, was an ending, a development so sudden and final that nothing else could happen. WBA continues to gather momentum, adding sales and stores in the U.S.
